Chronic hepatitis C and celiac sprue: An infrequent association;Hepatitis crónica por virus C y enfermedad celíaca: Una asociación infrecuente

Gastroenterologia y Hepatologia

Volumn 27, Issue 7, 2004, Pages 408-410

  Aguancha, I ^a   Valera, J M ^b   Hurtado, C ^b   Smok, G ^b   Brahm, Javier ^b  

^a HOSPITAL NAVAL ALMIRANTE NEF   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; INTERFERON; RIBAVIRIN;

ADULT; ARTICLE; CASE REPORT; CELIAC DISEASE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DISEASE ASSOCIATION; DUODENOSCOPY; DUODENUM BIOPSY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROSCOPY; HEPATITIS C; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; MALE; SYMPTOM; VIREMIA;

EID: 4544313648     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13064747     Document Type: Article

References (15)

1. Hagander B, Berg N, Brandt L, Norden A. Hepatic injury in adult coeliac disease. Lancet 1977;1:270-2.
2. Novacek G, Miehsler W, Wrba F. Prevalence and clinical importance of hypertransaminasaemia in coeliac disease. Eur J Gastroenterol Hepatol 1999;11:283-8.
3. Katri K, Leena H, Peca C. Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure. Gastroenterology 2002;122:881-8.
4. Bardella MT, Vecchi M, Conte D, Del Ninno E, Franquelli M. Chronic unexplained hypertransaminasemia may be caused by occult celiac disease. Hepatology 1999;29:654-7.
5. Volta U, De Franceschi L, Lari F. Coeliac disease hidden by cryptogenic hypertransaminasemia. Lancet 1998;352:26-9.
6. Dickey W, McMilan SA, Calleder ME. High prevalence of celiac sprue among patients with primary biliary cirrhosis. J Clin Gastroentrol 1997;25:328-9.
7. Hay JE, Wiesner RH, Shorter RG. Primary sclerosing cholangitis and celiac disease. A novel association. Ann Intern Med 1988;109:713-7.
8. Volta U, De Franceschi L, Molinaro M. Frequency and significance of anti-gliadin and anti-endomycial antibodies in autoimmune hepatitis. Dig Dis Sci 1998;43:120-2.
9. Fine K, Ogunji F, Saloum Y, Beharry S. Celiac sprue: another autoimmune syndrome associated with hepatitis C. Am J Gastroenterol 2001;96:139-45.
10. Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 1993;105:910-22.
11. Bardella M, Marino R, Meroni P. Celiac disease during Interferon treatment. Ann Intern Med 1999;131:157-8.
12. Cammarota G, Cuoco L, Cianci R. Onset of coeliac disease during treatment with interferon for chronic hepatitis C. Lancet 2000;356:1494-5.
13. Monteleone G, Pender SL, Alstead E. Role of INFα in promoting T helper cell type 1 responses in the small intestine in coeliac disease. Gut 2001;48:425-9.
14. Adinolfi L, Mangoni E, Andreana A. Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease. Am J Gastroenterol 2001;96:607-8.
15. Hultgren C, Milich D. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses. J Gen Virol 1998;79:2381-91.